Firma Actome, Autor bei PR-Web

Actome GmbH announces release of first commercial products

Posted on 5. May 20227. May 2022 by Firma Actome Posted in General Tagged actome, amulator, assay, customers, dna, dpcr, market, pcr, pico, protein, qiacuity, qiagen, research, rna, with

Actome has released the first commercial products to the EU market based on the Protein Interaction Coupling (PICO) Technology. The PICO assay kits for measuring proteins and protein interactions are available through our online webshop https://shop.actome.de Actome GmbH is a […]

Actome GmbH and QIAGEN announce commercial partnership

Posted on 7. January 2022 by Firma Actome Posted in General Tagged actome, biomarker, company, discovery, dna, market, new, pcr, pico, protein, qiacuity, qiagen, qiagen's, research, with

Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a license agreement and a co-marketing agreement with QIAGEN GmbH, Hilden, Germany, to jointly accelerate the market entry of Actome’s Protein-Interaction-Coupling (PICO) -Technology. The […]

Start-up Actome GmbH closes seed financing round

Posted on 1. July 20211. July 2021 by Firma Actome Posted in General Tagged accelerator, actome, biomarker, board, bvalue, bwcon, company, discovery, market, medical, pcr, research, science4life, supervisory, with

Actome GmbH, a life‐science start‐up company from the University of Freiburg and Hahn‐Schickard, Germany has closed a seed investment agreement with b.value AG, Düsseldorf, Germany and further investors. The seed investment will be used to establish the operative business and […]